Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study-Reference-Cited by-同舟云学术

Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study

Published:2012-03 Issue:1 Volume:11 Page:38-44
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Bennouna Jaafar,Borg Christophe,Delord Jean-Pierre,Husseini Faress,Trillet-Lenoir Véronique,Faroux Roger,François Eric,Ychou Marc,Goldwasser François,Bouché Olivier,Senellart Helene,Kraemer Sandrine,Douillard Jean-Yves

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference27 articles.

1. Advanced colorectal cancer: ESMO clinical practice guidelines for treatment;Van Cutsem;Ann Oncol,2010

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

3. Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer;Hurwitz;J Clin Oncol,2005

4. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer;Kabbinavar;J Clin Oncol,2003

5. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer;Kabbinavar;J Clin Oncol,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023);Clinical Surgical Oncology;2023-06

2. Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network;HPB;2022-12

3. Phase IIIb study of the bevacizumab biosimilar candidate BI 695502 plus mFOLFOX6 in metastatic colorectal cancer;Colorectal Cancer;2022-11-09

4. Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia;Journal of Oncology;2022-09-12

5. Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021 Featured Updates to the NCCN Guidelines;J NATL COMPR CANC NE;2021